PedAM

Pediatric Disease Annotations & Medicines

Disease	hepatitis a
Phenotype	C0023895\|liver disease
Sentences	27
PubMedID- 24742346	hepatitis a infection in patients with chronic viral liver disease: a cross-sectional study in jahrom, iran.
PubMedID- 23752047	Overlap syndromes are biochemical, serological, histological and radiological overlaps across the classic autoimmune liver diseases in the presence of autoimmun hepatitis and primary biliary cirrhosis or primary sclerosing cholangitis.
PubMedID- 24742271	Most of these infections cause chronic hepatitis and leading to progressive liver disease including cirrhosis, fibrosis and finally hepatocellular carcinoma (hcc) [3-5].
PubMedID- 19447449	[fatal acute hepatitis and cholestasis associated with liver disease].
PubMedID- 23559770	The common indications for liver transplantations were alcoholic cirrhosis, chronic liver disease associated with viral hepatitis and cryptogenic chronic liver disease [table 1].
PubMedID- 22906987	(aih) and viral hepatitis are inflammatory liver diseases in which liver damage is dependent to a great extent upon the infiltration of liver by cd4+ t cells producing the cytokine ifn-γ [1–3], also known as th1 cells.
PubMedID- 22448309	Reported four adults being assessed for liver transplantation because of chronic liver disease (three with cryptogenic hepatitis and one with congenital hepatic fibrosis) in whom cd was diagnosed following serological screening.
PubMedID- 25131040	The population had an average age of 57.5 years, predominantly formed by men (82.5%), with an average imc of 26.7, meld of 13, with viral hepatitis as main cause of liver disease.
PubMedID- 21057383	A better understanding of the importance of preventing acute hepatitis a and b in patients with chronic liver disease and a proactive approach to vaccination by primary care physicians can positively influence the outcome of patients with chronic liver disease.
PubMedID- 26058465	Persistent hbv infection can promote liver disease, thereby leading to hepatitis and cirrhosis [29].
PubMedID- 24890045	Methods: studies cited in pub med from 1972 to 2014 for autoimmune hepatitis, chemokines in liver disease, pathogenesis of autoimmune hepatitis and chemokine therapy were selected.
PubMedID- 23161302	Conclusions: pegylated interferon is as effective in patients with advanced liver disease due to chronic delta hepatitis as in patients with non-advanced liver disease, but patients should be monitored closely for clinically important side effects.
PubMedID- 21145841	Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity.
PubMedID- 25801076	Background: the pnpla3/adiponutrin rs738409 c/g single nucleotide polymorphism is associated with the severity of steatosis, steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease, as well as the severity of steatosis and fibrosis in patients with chronic hepatitis c (chc).
PubMedID- 24069490	These criteria also include symptoms of severe liver disease due to viral hepatitis a, b, c, and e (jaundice, hepatic encephalopathy, bleeding due to impaired synthesis of coagulation factors, and renal failure due to hepatorenal syndrome).
PubMedID- 22097893	Neutrophil to lymphocyte ratio: a new marker for predicting steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease.
PubMedID- 25862175	The pnpla3 p.ile148met variant and obesity: brothers-in-arms: comment on: pnpla3 genotype increases susceptibility of nonalcoholic steatohepatitis among obese patients with nonalcoholic fatty liver disease.
PubMedID- 20228784	All of the tumors in cirrhotic livers had chronic viral hepatitis as an underlying cause of liver disease (table 1).
PubMedID- 21167429	Severe forms of hepatitis are associated with underlying chronic liver disease such alcoholic disease.
PubMedID- 24786290	While hepatitis a infection is not associated with chronic liver disease in general, older and immunosuppressed people are susceptible to develop a fatal progression.
PubMedID- 25240529	Pnpla3 genotype increases susceptibility of nonalcoholic steatohepatitis among obese patients with nonalcoholic fatty liver disease.
PubMedID- 24456332	Alcohol-related liver disease (ald) is associated with steatohepatitis and insulin resistance.
PubMedID- 22511902	We also excluded patients with human immune-deficiency virus infection, hepatitis b virus co-infection, alcohol abuse, autoimmue hepatitis and other causes of liver disease.
PubMedID- 22346770	Alcoholic and nonalcoholic steatohepatitis are leading causes of liver diseases worldwide (41,82).
PubMedID- 26057287	Objectives: to illustrate how to identify patients with nonalcoholic fatty liver disease at greatest risk of nonalcoholic steatohepatitis and cirrhosis; to discuss the role and limitations of current diagnostics and liver biopsy to diagnose nonalcoholic steatohepatitis; and to provide an outline for the management of patients across the spectrum of nonalcoholic fatty liver disease.
PubMedID- 20215064	Chronic liver disease might be due to hemosiderosis and hepatitis and possibly to scd itself if small, clinically silent microvascular occlusions occur chronically.
PubMedID- 22452877	The elevated expression of cyp2e1, a microsomal oxidase involved in fatty acid ω-oxidation, as well as cyp4a, has been shown to be largely responsible for the pathogenesis of liver disease in patients with nonalcoholic steatohepatitis and plays a key role in the development of liver injury by initiating lipid peroxidation [3-7].

Page: 1